SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: crimson who wrote (10059)11/11/1998 2:37:00 PM
From: kendall harmon  Respond to of 119973
 
This is my attempt to summarize the news on OXGN: They announced today that the Company has begun testing and treating the first patient in a U.S. Phase I clinical trial of Combretastatin A-4 Pro drug for the treatment of solid tumors..



To: crimson who wrote (10059)11/11/1998 2:37:00 PM
From: Trader J  Read Replies (1) | Respond to of 119973
 
EGGS: Either way, looks like a pretty good play here. Off the high, the market is searching for direction, and more importantly I still think we are in eye of the Inet storm, I think buying is going to come in towards close......EGGS will go with it.....

A down market though and all bets are off. I am glad to see the nets pull back a bit, sentiment will be that they are still bargains.

I'm in EGGS now.

TJ


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News